US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 22, 2017 (9 years ago)

Caffeine Powder

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Marketed without an Approved NDA/ANDA: The product consists of pure, powdered caffeine and is an unapproved drug due to stimulant claims. The product is also misbranded as it fails to bear adequate directions for its intended use.

What was recalled

Caffeine Powder, Anhydrous, Pharmaceutical Grade, 100% Pure caffeine, 250 g (8.8 oz)., 1250 servings, Packed By: LifeLine Nutrients Corp, 1801 S. Canal St, Chicago, IL 60616, UPC 021754905076

Recalling firm
Global Marketing Enterprises, Inc.
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1096-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Caffeine recalls

See all
Class II · Moderate risk Ongoing

Acetaminophen 500mg Caffeine 65mg caplets

Reason Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The inner pouch correctly states the ingredients are Aspirin (NSAID)*500mg and Caffeine 32.5mg.

Aero Healthcare NDC 55305-135-01 D-0155-2026
Class I · High risk Ongoing

Healthy Living Acetaminophen

Reason Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.

Aurobindo Pharma USA Inc NDC 58602-882-21 D-0641-2024
Class II · Moderate risk Terminated

DBI Magnums Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-941-00 D-0554-2022
Class II · Moderate risk Terminated

Coated Back Relief Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-800-00 D-0553-2022
Class II · Moderate risk Terminated

Migrenol Caplet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-565-00 D-0547-2022